Rocaglamide Prolonged Allograft Survival by Inhibiting Differentiation of Th1/Th17 Cells in Cardiac Transplantation.

Dai C, Zhou X, Wang L, Tan R, Wang W, Yang B, Zhang Y, Shi H, Chen D, Wei L, Chen Z

Open source

DOI
10.1155/2022/2048095
Published
2022
Container
Oxidative medicine and cellular longevity
Publisher
Not recorded
Open access
yes

Credibility signals

serious concern Score 10/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1155/2022/2048095,
  title = {Rocaglamide Prolonged Allograft Survival by Inhibiting Differentiation of Th1/Th17 Cells in Cardiac Transplantation.},
  author = {Dai C and Zhou X and Wang L and Tan R and Wang W and Yang B and Zhang Y and Shi H and Chen D and Wei L and Chen Z},
  year = {2022},
  journal = {Oxidative medicine and cellular longevity},
  doi = {10.1155/2022/2048095},
  url = {https://doi.org/10.1155/2022/2048095}
}

RIS

TY  - JOUR
TI  - Rocaglamide Prolonged Allograft Survival by Inhibiting Differentiation of Th1/Th17 Cells in Cardiac Transplantation.
AU  - Dai C
AU  - Zhou X
AU  - Wang L
AU  - Tan R
AU  - Wang W
AU  - Yang B
AU  - Zhang Y
AU  - Shi H
AU  - Chen D
AU  - Wei L
AU  - Chen Z
PY  - 2022
JO  - Oxidative medicine and cellular longevity
DO  - 10.1155/2022/2048095
UR  - https://doi.org/10.1155/2022/2048095
ER  - 

APA

C, D., X, Z., L, W., R, T., W, W., B, Y., Y, Z., H, S., D, C., L, W., & Z, C. (2022). Rocaglamide Prolonged Allograft Survival by Inhibiting Differentiation of Th1/Th17 Cells in Cardiac Transplantation.. Oxidative medicine and cellular longevity. https://doi.org/10.1155/2022/2048095

Source records